MolMed expands in the United States the Phase III trial of TK for the treatment of high-risk leukaemia

May 30, 2016 | Author: social_molmed | Category: Types, Articles & News Stories


Description

MolMed announces the enrolment of the first patient in the United States, initiating the cross-Atlantic expansion of the...

Comments

SUPPORT DOCURI